Matthias Urmann

Matthias Urmann (* 1964 ) is a German chemist and manager. In 2018 he became President of the Society of German Chemists .

Urmann studied chemistry from 1983 at the University of Heidelberg with a diploma in 1989 and received his doctorate in 1992 under Günter Helmchen (dissertation: First total synthesis of enantiomerically pure ent-Juvabione ). In 1992/93 he was a post-doctoral student at Harvard University with Elias J. Corey . From 1993 he was laboratory manager in medical chemistry at Hoechst AG and from 2000 to 2008 head of the medicinal chemistry section. From 2008 he headed administration for research and development at Sanofi Germany (emerged from Hoechst AG) and from 2010 he headed the insulins and peptides department in the diabetes research and translational medicine department at Sanofi. He then headed the external innovations department.

Urmann deals with therapeutic approaches for diabetes mellitus .

He was a scholarship holder of the Fonds der Chemischen Industrie. In 2012 he became deputy chairman of the Liebig Association for Organic Chemistry of the Society of German Chemists and in 2018 President of the Society of German Chemists. He is a board member of Science4Life , an initiative that supports startups.

Web links

• GDCh press release on the election of Urmann 2017